Michael A. Dengler

1.5k total citations
24 papers, 706 citations indexed

About

Michael A. Dengler is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael A. Dengler has authored 24 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Michael A. Dengler's work include Cell death mechanisms and regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Michael A. Dengler is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Michael A. Dengler collaborates with scholars based in Germany, Australia and Austria. Michael A. Dengler's co-authors include Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Martin Pichler, Philipp J. Jost, Felix Prinz, George A. Călin, Moshe Oren, Jerry M. Adams and Ernst Bayer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Michael A. Dengler

24 papers receiving 697 citations

Peers

Countries citing papers authored by Michael A. Dengler

Since Specialization

Citations

This map shows the geographic impact of Michael A. Dengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Dengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Dengler more than expected).

Fields of papers citing papers by Michael A. Dengler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Dengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Dengler. The network helps show where Michael A. Dengler may publish in the future.

Co-authorship network of co-authors of Michael A. Dengler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Dengler. A scholar is included among the top collaborators of Michael A. Dengler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Dengler. Michael A. Dengler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner 2022 ·Oncogene ·(unknown), Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, Michelle Dietzen, (unknown), Martina Anton, Anne Jacob, Katja Steiger, Wilko Weichert, Luka Brčić, Nicholas McGranahan, Caterina Branca, Thomas Kaufmann, Michael A. Dengler, Philipp J. Jost	10
2	Non-coding RNAs and ferroptosis: potential implications for cancer therapy 2022 ·Cell Death and Differentiation ·(unknown), Felix Prinz, Michael A. Dengler, George A. Călin, Philipp J. Jost, Martin Pichler	105
3	The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax 2022 ·Blood ·(unknown), (unknown), (unknown), (unknown), Barbara Uhl, Hildegard Greinix, Peter Neumeister, Eva Bernhart, Christine Beham‐Schmid, Michael A. Dengler, (unknown), Alexander Deutsch	2
4	BAX mitochondrial integration is regulated allosterically by its α1−α2 loop 2021 ·Cell Death and Differentiation ·Michael A. Dengler, Leonie Gibson, Jerry M. Adams	6
5	Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL 2021 ·Blood ·Piers Blombery, Thomas E. Lew, Michael A. Dengler, Ella R. Thompson, Victor S. Lin, Xiangting Chen, Tamia Nguyen, Ashis Kumar Panigrahi, Sasanka M. Handunnetti, Dennis Carney, David Westerman, Constantine S. Tam, Jerry M. Adams, Andrew H. Wei, David C.S. Huang, John F. Seymour, Andrew W. Roberts, Mary Ann Anderson	47
6	Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target 2020 ·Cell Death and Disease ·Sweta Iyer, Rachel T. Uren, Michael A. Dengler, (unknown), (unknown), Jerry M. Adams, Grant Dewson, Ruth M. Kluck	28
7	Characterization of a novel human BFL-1-specific monoclonal antibody 2019 ·Cell Death and Differentiation ·Lahiru Gangoda, Charis E. Teh, Michael A. Dengler, Sarah A. Best, Clare E. Weeden, Lin Tai, Erinna F. Lee, W. Douglas Fairlie, (unknown), Leonard C. Harrison, Daniel H.D. Gray, Andreas Strasser, Marco J. Herold	3
8	Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma 2019 ·Oncogene ·Michael A. Dengler, Charis E. Teh, Rachel Thijssen, Lahiru Gangoda, Ping Lan, Marco J. Herold, Daniel H.D. Gray, Gemma L. Kelly, Andrew W. Roberts, Jerry M. Adams	18
9	BAX Activation: Mutations Near Its Proposed Non-canonical BH3 Binding Site Reveal Allosteric Changes Controlling Mitochondrial Association 2019 ·Cell Reports ·Michael A. Dengler, A.Y. Robin, Leonie Gibson, Xiang Li, Jarrod J. Sandow, Sweta Iyer, Andrew I. Webb, Dana Westphal, Grant Dewson, Jerry M. Adams	40
10	Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities 2018 ·Cell Reports ·Stephanie Grabow, Andrew J. Kueh, Francine Ke, Hannah Vanyai, Bilal N. Sheikh, Michael A. Dengler, (unknown), (unknown), Ian Smyth, Lynelle K. Jones, Frédéric J. de Sauvage, Mark Scott, Lachlan Whitehead, Anne K. Voss, Andreas Strasser	29
11	Cyclin D1 Driven CDK4 Activity Is Responsible for Hypersensitivity to NOXA Inducing Combination Treatment in Mantle Cell Lymphoma (MCL) Cells 2017 ·Blood ·Simon Heine, (unknown), Michael A. Dengler, Markus Kleih, German Ott, (unknown), (unknown), Heiko van der Kuip, Walter E. Aulitzky	1
12	BAK α6 permits activation by BH3-only proteins and homooligomerization via the canonical hydrophobic groove 2017 ·Proceedings of the National Academy of Sciences ·Xiang Li, Iris K. L. Tan, Stephen Ma, Colin Hockings, Tobias Kratina, Michael A. Dengler, Amber E. Alsop, Ruth M. Kluck, Grant Dewson	31
13	Die Implantatentfernung – eine Risiko-Nutzen-Abwägung? 2016 ·OP-Journal ·(unknown), (unknown), Michael A. Dengler, Bernd Füchtmeier	5
14	Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles’ heel in mantle cell lymphoma 2014 ·Cell Death and Disease ·Michael A. Dengler, (unknown), Matthias Gutekunst, Annette M. Staiger, Matthias Vöhringer, Heike Horn, German Ott, Walter E. Aulitzky, Heiko van der Kuip	43
15	Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4 2013 ·Cancer Research ·Matthias Gutekunst, Thomas Mueller, (unknown), Michael A. Dengler, Jens Bedke, Stephan Kruck, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip	47
16	The Phenotype High Noxa mRNA/Low NOXA Protein Levels Constitutes a Critical Achilles Heel Of Mantle Cell Lymphoma (MCL) Cells 2013 ·Blood ·Michael A. Dengler, (unknown), Matthias Gutekunst, Annette M. Staiger, Heike Horn, German Ott, Heiko van der Kuip, Walter E. Aulitzky	2
17	Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach 2012 ·European Heart Journal ·Ali Yılmaz, Michael A. Dengler, Heiko van der Kuip, (unknown), Sabine Rösch, Siegfried Klumpp, Karin Klingel, Reinhard Kandolf, Xavier Helluy, Karl‐Heinz Hiller, Peter M. Jakob, Udo Sechtem	118
18	Oncogenic Stress Induced by Acute Hyper-Activation of Bcr-Abl Leads to Cell Death upon Induction of Excessive Aerobic Glycolysis 2011 ·PLoS ONE ·Michael A. Dengler, Annette M. Staiger, Matthias Gutekunst, Ute Hofmann, (unknown), Peter Scheurich, Matthias Schwab, Walter E. Aulitzky, Heiko van der Kuip	24
19	p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin 2011 ·PLoS ONE ·Matthias Gutekunst, Moshe Oren, (unknown), Michael A. Dengler, (unknown), Jürgen Thomale, Walter E. Aulitzky, Heiko van der Kuip	76
20	Peptide synthesis on the new polyoxyethylene‐polystyrene graft copolymer, synthesis of insulin B 21–30 1985 ·International journal of peptide & protein research ·Ernst Bayer, Michael A. Dengler, (unknown)	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact